1. Rovina N, Akinosoglou K, Eugen-Olsen J, Hayek S, Reiser J, et al. Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia. Critical care. BioMed Central. 2020; 24:187-189. Available from: https://ccforum.biomedcentral.com/track/pdf/10.1186/s13054-020-02897-4
2. Astuti T, Yudani T, Riawan W, Muktiati NS, Widjajanto E. Profil kadar Soluble urokinase plasminogen activator receptor (suPAR) pada serum penderita tuberkulosis paru (sebagai monitoring terapi). Jurnal kedokteran Brawijaya. 2008; XXIV(1):30-35. Available From: https://jkb.ub.ac.id/index.php/jkb/article/view/350/339
3. Tornkvist PBS, Haupt TH, Rasmussen LJH, Ladelund S, Toft U, Pisinger C, Eugen-Olsen J. Soluble urokinase plasminogen activator receptor (suPAR) is linearly associated with dietary quality and predicts mortality. British Journal of Nutrition. 2019; 1:1-10. Available From: DOI:10.1017/S0007114518003720